Insider buying
~$101K56K sh @ $1.81
First buy since 2023Traded Dec 19, 2025 · filed 4 days later
Since the trade +67.6% · S&P 500 +1.4% · to Nov 20
Bought 44% below the 52-week high, RSI 42, 11% under its 200-day average, 17 points behind the S&P 500 over 3 months
The CEO of Protalix Biotherapeutics paid $101K out of pocket for Protalix Biotherapeutics shares. Shares held went up 42% with this purchase.